MSK Commack — Commack, New York

MSK Commack is a clinical research site located in Commack, New York, United States 11725.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

MSK Commack has participated in 12 clinical trials with 8 currently active.

Therapeutic areas: Multiple Myeloma, Advanced Malignancies, NSCLC.

Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer, Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MSK Commack?

MSK Commack has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MSK Commack conducted?

MSK Commack has 12 clinical trials on record, with 8 currently active. Their work covers Multiple Myeloma, Advanced Malignancies, NSCLC.

Is MSK Commack accredited by Crixeo Health?

Yes — MSK Commack holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about MSK Commack?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.